Pieris Pharmaceuticals Inc.
13F holders, Q2 2025 (June 30)2holders −23
2new positions
0sold out
$27.75avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Pieris Pharmaceuticals Inc. in their 13F filings, down 23 from Q3 2024. 2 opened new positions and 0 sold out. The largest holders were Farther Finance Advisors, LLC ($68) and Twin Peaks Wealth Advisors, LLC ($43).
- Company
- Pieris Pharmaceuticals Inc.
- Filed as
- PALVELLA THERAPEUTICS INC NEW COM (Q2 2025)
- CUSIP
- 720795202
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $111 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q2 2025: 4 shares bought, net +4 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Farther Finance Advisors, LLC | 0.00% | New | 3 | $68 |
| Twin Peaks Wealth Advisors, LLC | 0.00% | New | 1 | $43 |
"% of holder's portfolio" is PIERIS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Pieris Pharmaceuticals Inc. the manager owns.